PriceTargets.com logo

Apyx Medical - APYX Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $6.17
  • Forecasted Upside: 346.86%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$1.38 As of 04/18/2024 01:00 AM ET
▲ +0.06 (4.55%)

This chart shows the closing price for APYX by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Apyx Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for APYX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for APYX

Analyst Price Target is $6.17
▲ +346.86% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Apyx Medical in the last 3 months. The average price target is $6.17, with a high forecast of $9.00 and a low forecast of $4.50. The average price target represents a 346.86% upside from the last price of $1.38.

This chart shows the closing price for APYX for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 2 polled investment analysts is to buy stock in Apyx Medical. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/26/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/24/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/24/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/23/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/21/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/19/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/19/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/18/2024

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/10/2023StephensLower TargetOverweight ➝ Overweight$8.00 ➝ $5.00Low
8/11/2023Piper SandlerBoost TargetOverweight ➝ Overweight$4.00 ➝ $4.50Low
7/13/2023StephensInitiated CoverageOverweight$8.00Low
6/15/2023Lake Street CapitalBoost Target$6.00 ➝ $9.00Low
5/12/2023Lake Street CapitalBoost Target$5.00 ➝ $6.00Low
12/8/2022Lake Street CapitalReiterated RatingBuy$5.00Low
11/16/2022Piper SandlerLower Target$3.00N/A
11/16/2022Craig HallumLower Target$10.00N/A
11/11/2022Lake Street CapitalLower Target$18.00 ➝ $10.00Low
11/10/2022JMP SecuritiesDowngradeOutperform ➝ Market PerformLow
11/10/2022Piper SandlerLower Target$12.00 ➝ $3.00Low
8/12/2022Piper SandlerBoost TargetOverweight$6.00 ➝ $12.00Low
7/19/2022Lake Street CapitalBoost TargetBuy$14.00 ➝ $17.00Low
7/11/2022Lake Street CapitalBoost Target$12.00 ➝ $14.00N/A
5/20/2022Lake Street CapitalInitiated CoverageBuy$12.00Medium
5/12/2022Piper SandlerLower Target$12.00 ➝ $6.00High
3/22/2022Colliers SecuritiesReiterated RatingBuyLow
3/17/2022Piper SandlerLower Target$20.00 ➝ $12.00Medium
11/12/2021JMP SecuritiesReiterated RatingBuy$17.00High
11/11/2021Piper SandlerBoost TargetOverweight$14.00 ➝ $20.00High
8/13/2021JMP SecuritiesBoost TargetMarket Outperform$12.00 ➝ $14.00Medium
6/28/2021Colliers SecuritiesReiterated RatingBuy$14.00Medium
3/30/2021Colliers SecuritiesReiterated RatingBuyLow
1/29/2021Piper SandlerBoost TargetOverweight$8.00 ➝ $12.00Low
5/12/2020JMP SecuritiesLower TargetMarket Outperform$7.00 ➝ $5.00High
3/17/2020Piper SandlerLower Target$10.00 ➝ $7.00High
11/11/2019Piper Sandler CompaniesBoost TargetOverweight$10.00High
5/8/2019Piper Sandler CompaniesLower TargetOverweight$7.00High
(Data available from 4/19/2019 forward)

News Sentiment Rating

-0.17 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 4 very positive mentions
  • 6 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
1/20/2024
  • 2 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 1 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 2 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 1 very positive mentions
  • 10 positive mentions
  • 3 negative mentions
  • 2 very negative mentions

Recent Stories by Sentiment

Very Negative

Negative

Positive

Very Positive

Apyx Medical logo
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. Its Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also develops and manufactures hand pieces for open and laparoscopic procedures; and OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
Read More

Today's Range

Now: $1.38
Low: $1.26
High: $1.39

50 Day Range

MA: $1.82
Low: $1.25
High: $2.71

52 Week Range

Now: $1.38
Low: $1.21
High: $7.97

Volume

66,774 shs

Average Volume

148,261 shs

Market Capitalization

$47.80 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Frequently Asked Questions

What sell-side analysts currently cover shares of Apyx Medical?

The following Wall Street sell-side analysts have issued stock ratings on Apyx Medical in the last year: Lake Street Capital, Piper Sandler, and Stephens.
View the latest analyst ratings for APYX.

What is the current price target for Apyx Medical?

3 Wall Street analysts have set twelve-month price targets for Apyx Medical in the last year. Their average twelve-month price target is $6.17, suggesting a possible upside of 346.9%. Lake Street Capital has the highest price target set, predicting APYX will reach $9.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $4.50 for Apyx Medical in the next year.
View the latest price targets for APYX.

What is the current consensus analyst rating for Apyx Medical?

Apyx Medical currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe APYX will outperform the market and that investors should add to their positions of Apyx Medical.
View the latest ratings for APYX.

What other companies compete with Apyx Medical?

Other companies that are similar to Apyx Medical include Beyond Air, Daxor, Autonomix Medical, Health Sciences Acquisitions Co. 2 and Sensus Healthcare. Learn More about companies similar to Apyx Medical.

How do I contact Apyx Medical's investor relations team?

Apyx Medical's physical mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The company's listed phone number is (727) 384-2323 and its investor relations email address is [email protected]. The official website for Apyx Medical is www.apyxmedical.com. Learn More about contacing Apyx Medical investor relations.